I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Nasnas, Cedric
27
results:
Search for persons
X
Format
Online (27)
Mediatypes
Articles (Online) (11)
OpenAccess-fulltext (16)
Sorted by: Relevance
Sorted by: Year
?
1
Using Proton Pump Inhibitors is not Associated With Adverse..:
Haddad, Fadi G.
;
Nasnas, Cedric
;
Sasaki, Koji
...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 7 - p. 484-487 , 2024
Link:
https://doi.org/10.1016/..
?
2
Combination of dasatinib and venetoclax in newly diagnosed ..:
Jabbour, Elias
;
Haddad, Fadi G.
;
Sasaki, Koji
...
Cancer. 130 (2024) 15 - p. 2652-2659 , 2024
Link:
https://doi.org/10.1002/..
?
3
Comprehensive characterization of IFNγ signaling in acute m..:
Wang, Bofei
;
Reville, Patrick K.
;
Yassouf, Mhd Yousuf
...
Nature Communications. 15 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
4
P373: UPDATES FROM A PHASE II TRIAL OF MINI-HYPER-CVD-INOTU..:
Haddad, Fadi
;
Jabbour, Elias
;
Nasnas, Cedric
...
HemaSphere. 7 (2023) S3 - p. e3563066 , 2023
Link:
https://doi.org/10.1097/..
?
5
S118: A CHEMOTHERAPY-FREE COMBINATION OF PONATINIB AND BLIN..:
Short, Nicholas
;
Jabbour, Elias
;
Jain, Nitin
...
HemaSphere. 7 (2023) S3 - p. e4968152 , 2023
Link:
https://doi.org/10.1097/..
?
6
S119: COMBINATION OF MINI-HYPER-CVD AND INOTUZUMAB (INO) FO..:
Haddad, Fadi
;
Jabbour, Elias
;
Nasnas, Cedric
...
HemaSphere. 7 (2023) S3 - p. e89468e9 , 2023
Link:
https://doi.org/10.1097/..
?
7
P485: AZACITIDINE, VENETOCLAX AND GILTERITINIB FOR PATIENTS..:
Short, Nicholas
;
Macaron, Walid
;
Dinardo, Courtney
...
HemaSphere. 7 (2023) S3 - p. e535260f , 2023
Link:
https://doi.org/10.1097/..
?
8
P379: PONATINIB AND BLINATUMOMAB IN RELAPSED/REFRACTORY PHI..:
Haddad, Fadi
;
Jabbour, Elias
;
Zoghbi, Marianne
...
HemaSphere. 7 (2023) S3 - p. e6913408 , 2023
Link:
https://doi.org/10.1097/..
?
9
P358: HYPER-CVAD WITH BLINATUMOMAB AND INOTUZUMAB OZOGAMICI..:
Short, Nicholas
;
Jabbour, Elias
;
Jain, Nitin
...
HemaSphere. 7 (2023) S3 - p. e67564ca , 2023
Link:
https://doi.org/10.1097/..
?
10
P377: A PHASE II TRIAL OF MINI-HYPER-CVD WITH VENETOCLAX FO..:
Haddad, Fadi
;
Jabbour, Elias
;
Zoghbi, Marianne
...
HemaSphere. 7 (2023) S3 - p. e9487430 , 2023
Link:
https://doi.org/10.1097/..
?
11
P364: A PHASE II STUDY OF LOW-INTENSITY CHEMOTHERAPY (MINI-..:
Haddad, Fadi
;
Jabbour, Elias
;
Nasr, Lewis
...
HemaSphere. 7 (2023) S3 - p. e117201f , 2023
Link:
https://doi.org/10.1097/..
?
12
P364: A PHASE II STUDY OF LOW-INTENSITY CHEMOTHERAPY (MINI-..:
Haddad, Fadi
;
Jabbour, Elias
;
Nasr, Lewis
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428448/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
13
P373: UPDATES FROM A PHASE II TRIAL OF MINI-HYPER-CVD-INOTU..:
Haddad, Fadi
;
Jabbour, Elias
;
Nasnas, Cedric
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428515/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
14
P379: PONATINIB AND BLINATUMOMAB IN RELAPSED/REFRACTORY PHI..:
Haddad, Fadi
;
Jabbour, Elias
;
Zoghbi, Marianne
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428366/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
15
P485: AZACITIDINE, VENETOCLAX AND GILTERITINIB FOR PATIENTS..:
Short, Nicholas
;
Macaron, Walid
;
Dinardo, Courtney
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429552/. , 2023
Link:
http://www.ncbi.nlm.nih...
1-15
